Conning Inc. held its position in shares of Humana Inc. (NYSE:HUM) during the second quarter, Holdings Channel reports. The institutional investor owned 3,873 shares of the insurance provider’s stock at the end of the second quarter. Conning Inc.’s holdings in Humana were worth $697,000 at the end of the most recent quarter.
Several other institutional investors also recently made changes to their positions in the stock. NN Investment Partners Holdings N.V. bought a new position in shares of Humana during the first quarter worth $3,104,000. Columbia Partners L L C Investment Management raised its position in shares of Humana by 6.5% in the first quarter. Columbia Partners L L C Investment Management now owns 10,476 shares of the insurance provider’s stock worth $1,916,000 after buying an additional 638 shares during the period. Howard Hughes Medical Institute raised its position in shares of Humana by 67.3% in the first quarter. Howard Hughes Medical Institute now owns 8,380 shares of the insurance provider’s stock worth $1,533,000 after buying an additional 3,372 shares during the period. BlackRock Group LTD raised its position in shares of Humana by 0.8% in the first quarter. BlackRock Group LTD now owns 1,440,963 shares of the insurance provider’s stock worth $263,624,000 after buying an additional 10,939 shares during the period. Finally, Rehmann Capital Advisory Group raised its position in shares of Humana by 0.4% in the first quarter. Rehmann Capital Advisory Group now owns 1,506 shares of the insurance provider’s stock worth $276,000 after buying an additional 6 shares during the period. Institutional investors own 93.24% of the company’s stock.
Shares of Humana Inc. (NYSE:HUM) traded down 0.43% during midday trading on Thursday, hitting $175.82. 367,391 shares of the company were exchanged. Humana Inc. has a one year low of $150.00 and a one year high of $191.65. The stock has a market cap of $26.21 billion, a PE ratio of 27.01 and a beta of 0.91. The stock’s 50-day moving average is $177.23 and its 200-day moving average is $176.36.
Humana (NYSE:HUM) last posted its earnings results on Wednesday, August 3rd. The insurance provider reported $2.30 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $2.23 by $0.07. The company earned $14 billion during the quarter, compared to the consensus estimate of $13.59 billion. Humana had a net margin of 1.76% and a return on equity of 11.11%. The company’s revenue for the quarter was up 2.0% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.67 earnings per share. Equities research analysts anticipate that Humana Inc. will post $9.26 EPS for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Friday, October 28th. Shareholders of record on Thursday, October 13th will be given a $0.29 dividend. This represents a $1.16 annualized dividend and a yield of 0.66%. The ex-dividend date of this dividend is Tuesday, October 11th. Humana’s dividend payout ratio is 18.18%.
A number of equities analysts have weighed in on the stock. Leerink Swann reiterated an “outperform” rating on shares of Humana in a report on Tuesday, June 21st. Credit Suisse Group AG reiterated a “hold” rating on shares of Humana in a report on Tuesday, June 28th. Argus reiterated a “hold” rating on shares of Humana in a report on Tuesday, August 23rd. Cantor Fitzgerald reiterated a “buy” rating on shares of Humana in a report on Monday, August 8th. Finally, Wolfe Research started coverage on shares of Humana in a research note on Tuesday, June 28th. They issued a “market perform” rating and a $244.00 target price on the stock. Six investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. Humana currently has an average rating of “Buy” and an average price target of $200.93.
Humana Company Profile
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group, Healthcare Services and Other Businesses. The Retail segment consists of Medicare benefits, marketed to individuals or directly via group accounts, as well as individual commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM).
Receive News & Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related companies with MarketBeat.com's FREE daily email newsletter.